NEW YORK, Dec. 8, 2005 (PRIMEZONE) -- The Rosen Law Firm (http://rosenlegal.com) reminds investors that they have until December 12, 2005 to seek appointment by the Court as Lead Plaintiff in the class action lawsuit filed by the Rosen Law Firm on behalf of purchasers of Barrier Therapeutics, Inc, ("Barrier" or the "Company'') (Nasdaq:BTRX), common stock during the period between April 29, 2004 and June 29, 2005 (the "Class Period"). Shareholders who purchased Barrier stock in the Initial Public Offering ("IPO") on April 29, 2004 and/or in its Secondary Offering on February 9, 2005 are also included in this class action.
To join the Barrier class action, go to the website at http://www.rosenlegal.com or call Laurence Rosen, Esq. toll-free at 866-767-3653 or email lrosen@rosenlegal.com for information on the class action.
The complaint charges Barrier and certain of its officers and directors with violations of the Securities Act of 1933 and Securities Exchange Act of 1934. Barrier is a biopharmaceutical company, engaged in the discovery, development, and commercialization of pharmaceutical products in the field of dermatology. The complaint alleges that Barrier made a series of materially false and misleading statements concerning the Company's business and products under development. In particular, the Complaint alleges that these statements were materially false and misleading because they failed to disclose and misrepresented the following adverse facts: (i) that the Company had failed to perform its clinical trials in conformity with FDA guidelines as they had failed to disclose that they had secretly substituted the petroleum base within Zimycan, the effect of which was to substantially lessen the likelihood that the drug could achieve FDA approval; (ii) that Hyphanox did not have a better safety or efficacy profile than fluconazole/Diflucan and, in fact, as investors ultimately learned, Hyphanox was significantly less effective than fluconazole/Diflucan; and (iii) as a result of the foregoing, defendants lacked any reasonable basis for their positive statements about Barrier.
A class action lawsuit has already been filed on behalf of Barrier shareholders. If you wish to serve as lead plaintiff, you must move the Court no December 12, 2005. If you wish to join the litigation or to discuss your rights or interests regarding this class action, please contact plaintiff's counsel, Laurence Rosen, Esq. of The Rosen Law Firm toll free at 866-767-3653 or via e-mail at lrosen@rosenlegal.com .You can also join this class action online at http://www.rosenlegal.com The Rosen Law Firm http://www.rosenlegal.com has expertise in prosecuting investor securities litigation and extensive experience in actions involving financial fraud. The Rosen Law Firm represents investors throughout the nation, concentrating its practice in securities class actions.
More information on this and other class actions can be found on the Class Action Newsline at www.primezone.com/ca